Cognitive and behavioral determinants of psychotic symptoms in Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 39, Issue 3-4, 2015, Pages 194-206

  Quaranta, Davide ^a   Vita, Maria Gabriella ^a   Bizzarro, Alessandra ^a   Masullo, Carlo ^a   Piccininni, Chiara ^a   Gainotti, Guido ^a   Marra, Camillo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Alzheimer's disease; Delusional misidentifications; Delusions; Hallucinations; Neuropsychological assessment; Psychosis

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR CHANGE; COGNITIVE DEFECT; CONTROLLED STUDY; DELUSION; DELUSIONAL MISIDENTIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PARANOIA; PRIORITY JOURNAL; PSYCHOSIS; TASK PERFORMANCE; VISUAL HALLUCINATION; VISUAL MEMORY; AGE; CROSS-SECTIONAL STUDY; DELUSIONS; FRONTAL LOBE; HALLUCINATIONS; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PSYCHOLOGY; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DELUSIONS; FEMALE; FRONTAL LOBE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 84920849259     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000369161     Document Type: Article

References (46)

1. Ropacki SA, Jeste DV: Epidemiology of and risk factors for psychosis of Alzheimer's disease: A review of 55 studies published from 1990 to 2003. Am J Psychiatry 2005; 162: 2022-2030.
2. Scarmeas N, Brandt J, Albert M, Devanand DP, Marder K, Bell K, Ciappa A, Tycko B, Stern Y: Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology 2002; 58: 1182-1188.
3. Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV: Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology 2000; 54: 1965-1971.
4. Sweet RA, Nimgaonkar VL, Devlin B, Jeste DV: Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol Psychiatry 2003; 8: 383-392.
5. Burns A, Jacoby R, Levy R: Psychiatric phenomena in Alzheimer's disease. I. Disorders of thought content. Br J Psychiatry 1990; 157: 72-76, 92-94.
6. Burns A, Jacoby R, Levy R: Psychiatric phenomena in Alzheimer's disease. II. Disorders of perception. Br J Psychiatry 1990; 157: 76-81, 92-94.
7. Holt AEM, Albert ML: Cognitive neuroscience of delusions in aging. Neuropsychiatr Dis Treat 2006; 2: 181-189.
8. Ballard CG, Bannister CL, Patel A, Graham C, Oyebode F, Wilcock G, Chung MC: Classification of psychotic symptoms in dementia sufferers. Acta Psychiatr Scand 1995; 92: 63-68.
9. Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG: Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates. Int J Geriatr Psychiatry 2000; 15: 99-107.
10. Frisoni GB, Rozzini L, Gozzetti A, Binetti G, Zanetti O, Bianchetti A, Trabucchi M, Cummings JL: Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord 1999; 10: 130-138.
11. Levy ML, Cummings JL, Fairbanks LA, Bravi D, Calvani M, Carta A: Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry 1996; 153: 1438-1443.
12. Lopez OL, Becker JT, Sweet RA, Klunk W, Kaufer DI, Saxton J, Habeych M, DeKosky ST: Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2003; 15: 346-353.
13. Starr JM, Lonie J: Relationship between behavioural and psychological symptoms of dementia and cognition in Alzheimer's disease. Dement Geriatr Cogn Disord 2007; 24: 343-347.
14. Kotrla KJ, Chacko RC, Harper RG, Doody R: Clinical variables associated with psychosis in Alzheimer's disease. Am J Psychiatry 1995; 152: 1377-1379.
15. Jeste DV, Wragg RE, Salmon DP, Harris MJ, Thal LJ: Cognitive deficits of patients with Alzheimer's disease with and without delusions. Am J Psychiatry 1992; 149: 184-189.
16. Swanberg MM, Tractenberg RE, Mohs R, Thal LJ, Cummings JL: Executive dysfunction in Alzheimer disease. Arch Neurol 2004; 61: 556-560.
17. Hopkins MW, Libon DJ: Neuropsychological functioning of dementia patients with psychosis. Arch Clin Neuropsychol 2005; 20: 771-783.
18. Paulsen JS, Ready RE, Stout JC, Salmon DP, Thal LJ, Grant I, Jeste DV: Neurobehaviors and psychotic symptoms in Alzheimer's disease. J Int Neuropsychol Soc 2000; 6: 815-820.
19. Bruen PD, McGeown WJ, Shanks MF, Venneri A: Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain 2008; 131: 2455-2463.
20. Lopez OL, Smith G, Becker JT, Meltzer CC, DeKosky ST: The psychotic phenomenon in probable Alzheimer's disease: A positron emission tomography study. J Neuropsychiatry Clin Neurosci 2001; 13: 50-55.
21. Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL: Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000; 69: 167-171.
22. Sultzer DL, Brown CV, Mandelkern MA, Mahler ME, Mendez MF, Chen ST, Cummings JL: Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am J Psychiatry 2003; 160: 341-349.
23. Becker D, Hershkowitz M, Maidler N, Rabinowitz M, Floru S: Psychopathology and cognitive decline in dementia. J Nerv Ment Dis 1994; 182: 701-703.
24. Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA: Hallucinations, delusions, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000; 69: 173-177.
25. Perez-Madriñan G, Cook SE, Saxton JA, Miyahara S, Lopez OL, Kaufer DI, Aizenstein HJ, DeKosky ST, Sweet RA: Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype. Am J Geriatr Psychiatry 2004; 12: 446-456.
26. Feinberg TE, Shapiro RM: Misidentification-reduplication and the right hemisphere. Neuropsychiatry Neuropsychol Behav Neurol 1989; 2: 39-48.
27. Forstl H, Burns A, Jacoby R, Levy R: Neuroanatomical correlates of clinical misidentification and misperception in senile dementia. J Clin Psychiatry 1991; 52: 268-271.
28. Staff RT, Shanks MF, Macintosh L, Pestell SJ, Gemmell HG, Venneri A: Delusions in Alzheimer's disease: SPET evidence of right hemispheric dysfunction. Cortex 1999; 35: 549-560.
29. Horowitz MJ: Hallucinations: An information processing approach; in West LJ, Siegel RK (eds): Hallucinations: Behavior, Experience, and Theory. New York, Wiley, 1975, pp 163-194
30. Trzepacz PT, Meagher DJ: Neuropsychiatric aspects of delirium; in Yudofsky SC, Hales RE (eds): The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences. Arlington, American Psychiatric Publishing, 2008, pp 445-517.
31. Guidi M, Paciaroni L, Paolini S, De Padova S, Scarpino O: Differences and similarities in the neuropsychological profile of dementia with Lewy bodies and Alzheimer's disease in the early stage. J Neurol Sci 2006; 248: 120-123.
32. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263-269.
33. Binetti G, Mega MS, Magni E, Padovani A, Rozzini L, Bianchetti A, Trabucchi M, Cummings JL: Behavioral disorders in Alzheimer disease: A transcultural perspective. Arch Neurol 1998; 55: 539-544.
34. Cummings JL: The neuropsychiatric inventory: Assessing psychopathology in dementia patients. Neurology 1997; 48:S10-S16.
35. Carlesimo GA, Caltagirone C, Gainotti G: The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996; 36: 378-384.
36. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A: Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci 2002; 22: 443-447.
37. Monaco M, Costa A, Caltagirone C, Carlesimo GA: Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population. Neurol Sci 2013; 34: 749-754.
38. Caltagirone C, Gainotti G, Masullo C, Miceli G: Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr Scand 1979; 60: 50-56.
39. Marra C, Ferraccioli M, Gainotti G: Gender-related dissociations of categorical fluency in normal subjects and in subjects with Alzheimer's disease. Neuropsychology 2007; 21: 207-211.
40. Miceli G, Laudanna A, Burani C, Capasso R: Batteria per l'analisi dei deficit afasici b.A.D.A. Rome, CEPSAG, Università Cattolica del Sacro Cuore, 1994.
41. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A: Una versione abbreviata del test di Stroop: dati normativi nella popolazione italiana. Nuova Riv Neurol 2002; 12: 111-115.
42. Marra C, Gainotti G, Scaricamazza E, Piccininni C, Ferraccioli M, Quaranta D: The Multiple Features Target Cancellation (MFTC): An attentional visual conjunction search test. Normative values for the Italian population. Neurol Sci 2013; 34: 173-180.
43. Wilkosz PA, Miyahara S, Lopez OL, Dekosky ST, Sweet RA: Prediction of psychosis onset in Alzheimer disease: the role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes. Am J Geriatr Psychiatry 2006; 14: 352-360.
44. Gainotti G: Face familiarity feelings, the right temporal lobe and the possible underlying neural mechanisms. Brain Res Rev 2007; 56: 214-235.
45. Meppelink AM, de Jong BM, Renken R, Leenders KL, Cornelissen FW, van Laar T: Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 2009; 132: 2980-2993.
46. Cummings J, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R: Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations. J Alzheimers Dis 2010; 20: 301-311.